CHOICE OF ANTITHROMBOTIC DRUG IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD PRACTICE

被引：0
|
作者：
Citarella, A. [1 ]
Cammarota, S. [1 ]
Creazzola, S. [2 ]
De Marino, C. [2 ]
Izzo, P. [2 ]
La Bella, G. [2 ]
Piscitelli, R. [2 ]
Romagnuolo, F. [2 ]
Esposito, E. [2 ]
Guida, A. [2 ]
机构：
[1] LinkHealth Srl, Naples, Italy
[2] Local Hlth Author, Naples, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.806
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV38
引用
收藏
页码：A380 / A380
页数：1
相关论文
共 50 条
  • [1] The Unmet Needs of Antithrombotic Treatment in Patients with Non-Valvular Atrial Fibrillation in Real-World Clinical Practice
    Lau, W. C. Y.
    Chan, E. W.
    Liu, K.
    Wong, I. C. K.
    DRUG SAFETY, 2014, 37 (10) : 854 - 854
  • [2] Dabigatran in 'real-world' clinical practice for stroke prevention in patients with non-valvular atrial fibrillation
    Potpara, Tatjana S.
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (06) : 1093 - 1098
  • [3] The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients
    Valeriani, Emanuele
    Ageno, Walter
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 62 : 7 - 8
  • [4] Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
    Calderon, Jose Miguel
    Martinez, Fernando
    Diaz, Javier
    Fernandez, Antonio
    Sauri, Inmaculada
    Uso, Ruth
    Trillo, Jose Luis
    Vela, Sara
    Bea, Carlos
    Redon, Josep
    Forner, Maria Jose
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [5] Suboptimal Management of Patients with Non-valvular Atrial Fibrillation: Real-world Clinical Setting
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 380 - 380
  • [6] Persistence of Dabigatran Versus Warfarin Therapy in Patients with Non-valvular Atrial Fibrillation in the Real-world Clinical Practice
    Lau, Wallis C. Y.
    Chan, Esther W.
    Wong, Ian C. K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 382 - 382
  • [7] Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice
    Li, Xiaoyan
    Deitelzweig, Steve
    Keshishian, Allison
    Hamilton, Melissa
    Horblyuk, Ruslan
    Gupta, Kiran
    Luo, Xuemei
    Mardekian, Jack
    Friend, Keith
    Nadkarni, Anagha
    Pan, Xianying
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (06) : 1072 - 1082
  • [8] Real-World Analysis of Potential Pharmacokinetic and Pharmacodynamic Drug Interactions with Apixaban in Patients with Non-Valvular Atrial Fibrillation
    Badreldin, Hisham A.
    Alghamdi, Jahad
    Alshaya, Omar
    Alshehri, Abdulmajeed
    Alreshoud, Lamya
    Altoukhi, Renad
    Vasudevan, Senthilvel
    Ismail, Wesam W.
    Mohamed, Mohamed Salih Aziz
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2020, 13 : 419 - 427
  • [9] Antithrombotic strategies for the management of non-valvular atrial fibrillation
    Nixdorff, U
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 100 (02) : 191 - 198
  • [10] Real - world evidence of stroke prevention in patients with non-valvular atrial fibrillation
    Coleman, C.
    Antz, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 502 - 502
12345